This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Health Carerss

Interest Rises in Medivation Oncology Prospects

Shareholders have written consent to hold the target's board to task.

05/04/16 - 05:03 PM EDT

Bank of America's 17 High-Quality Cash-Rich Stocks for Investors to Consider

Looking for a cheat sheet of the best S&P 500 stocks? Bank of America found 17 high quality, cash-rich ones for you to consider.

05/04/16 - 09:33 AM EDT

Try Jim Cramer's Action Alerts PLUS
How to Trade 5 Health Insurance Companies

How to Trade 5 Health Insurance Companies

Here's how to use technical charts to trade health insurance companies Aetna, Anthem, Cigna, Centene and UnitedHealth.

05/04/16 - 08:09 AM EDT

Why Acadia Pharma's First Drug Approval Isn't Moving Stock Higher

Why Acadia Pharma's First Drug Approval Isn't Moving Stock Higher

  • Tickers in this article:
  • ACAD

A number of factors help explain the less-than-celebratory reaction to the approval of Acadia Pharma's first drug, Nuplazid.

05/03/16 - 10:03 AM EDT

Don't Give Up on Gilead Following a Weak Q1

Don't Give Up on Gilead Following a Weak Q1

  • Tickers in this article:
  • GILD
  • MRK

After reporting a disappointing first quarter on Friday, the biopharma company could regain some value amid court developments over its patent lawsuit with Merck.

05/02/16 - 11:46 AM EDT

Must-See Charts: How Healthy Are Bristol-Myers, Eli Lilly, Pfizer, Merck?

Must-See Charts: How Healthy Are Bristol-Myers, Eli Lilly, Pfizer, Merck?

Should you be trading these health care stocks? Let's look at the technical charts.

05/02/16 - 09:20 AM EDT

Reversal of Fortune: Energy Sector Fires Up as Tech and Health Fizzle

Reversal of Fortune: Energy Sector Fires Up as Tech and Health Fizzle

In the week ahead, new earnings and economic data will indicate whether the energy sector's resurgence, in tandem with the decline of technology and health stocks, will continue.

05/01/16 - 03:41 PM EDT

What Does It Take to Outperform the S&P 500? We Asked a Board Member Who Does It

What Does It Take to Outperform the S&P 500? We Asked a Board Member Who Does It

Pharmaceutical veteran Carrie Cox was highlighted by TheStreet as a great addition to any board of directors. She shares her thoughts on what it means to be a good director.

04/30/16 - 10:27 AM EDT

Government Probes for Valeant; New Board Members Put Forth

Government Probes for Valeant; New Board Members Put Forth

The embattled pharmaceutical company's move to bring in additional directors and file an overdue financial report did little to appease the markets.

04/29/16 - 01:38 PM EDT

Look to the Companies; Chinese Demand Is for Real: Jim Cramer’s Best Blogs

Look to the Companies; Chinese Demand Is for Real: Jim Cramer’s Best Blogs

Jim Cramer looks carefully and prefers the companies over German data, and considers papers and plastics in China.

04/29/16 - 10:51 AM EDT

Sanofi First Quarter Shows Why It Wants but Doesn't Need Medivation

Sanofi First Quarter Shows Why It Wants but Doesn't Need Medivation

The San Francisco target rejects the $9.3 billion offer, but biotech growth and a healthy pipeline mean Sanofi isn't desperate for Medivation's cancer treatments.

04/29/16 - 10:50 AM EDT

'Lives Are at Stake' With GE Health-Care Cuts, Retirees Tell Immelt

'Lives Are at Stake' With GE Health-Care Cuts, Retirees Tell Immelt

  • Tickers in this article:
  • GE

GE retirees, many of whom hold stock in their former employer, used Wednesday's annual meeting to urge CEO Jeffrey Immelt to reconsider cuts to their health-care benefits.

04/28/16 - 02:06 PM EDT

Jim Cramer: Investors Should Flock to Pharma

Jim Cramer: Investors Should Flock to Pharma

Cramer remains bullish on drug makers including Johnson & Johnson, Bristol-Myers and Allergan.

04/28/16 - 01:55 PM EDT

$40 Billion Takeover Has Big Pharma Giddy

$40 Billion Takeover Has Big Pharma Giddy

Thursday's parade of deals seem to answer a question that's been bugging health care investors for most of 2016: why haven't retreating biotech valuations sparked an uptick in M&A activity?

04/28/16 - 01:30 PM EDT

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

Markets

Chart of I:DJI
DOW 17,690.09 +38.83 0.22%
S&P 500 2,057.30 +6.18 0.30%
NASDAQ 4,732.1250 +6.4860 0.14%
Top Rated Stocks Top Rated Funds Top Rated ETFs